Eastman Chemical Company

to Greg Riddle of Eastman, Investor Relations. Please go ahead, sir.

Okay, thank you, Lydia, and good morning, everyone, and thank you for joining us. On the call with me today are Mark Costa, Board Chair and CEO, Willie McLean, Executive Vice President and CFO, and Jake Leroux, Manager, Investor Relations. Yesterday, after market closed, we posted our first quarter 2024 financial results news release and SEC 8K filing. Our slides and the related prepared remarks in the investor section of our website, www.eisman.com. Before we begin, I'll cover two items. First, during this presentation, you will hear certain forward-looking statements concerning our plans and expectations. Actual events or results could differ materially. Certain factors related to future expectations are or will be detailed in our first quarter 2024 financial results news release during this call. in the preceding slides and prepared remarks, and in our filings with the SEC, including the Form 10-K, filed for year 2023, and the Form 10-Q to be filed for first quarter of 2024. Second, earnings referenced in this presentation exclude certain non-core and unusual items, reconciliations to the most directly comparable GAAP financial measures and other associated disclosures, including a description of the excluded and adjusted items, are available in the first quarter 2024 financial results news release. As we posted the slides and accompanying prepared remarks on our website last night, we will now go straight into Q&A. Lydia, please let's start with our first question.

Thank you. So please press star followed by the number one if you'd like to ask a question and ensure your device is unmuted locally when it's your turn to speak. A kind reminder to please ask one question and one follow-up only. Our first question today comes from Vincent Andrews of Morgan Stanley. Please go ahead. Your line is open.